- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03093792
Effects of Diet Manipulation on Women in the Curves Program (Curves2)
March 22, 2017 updated by: Texas A&M University
Effects of a Carbohydrate Restricted, High Protein, High Fat Diet on Weight Loss and Health Outcomes in Women Participating in the Curves Fitness and Weight Loss Program
The purpose of this study is to look at the effects of a carbohydrate restricted, high protein, high fat diet on weight loss and health outcomes in women participating in the Curves Fitness and Weight Loss Program.
Study Overview
Status
Completed
Conditions
Detailed Description
The purpose of this study is to determine if a carbohydrate restricted, high protein, high fat diet (20% carbohydrate, 45% protein, 35% fat; CC-II) promotes more favorable changes in weight loss and health outcomes compared to a traditional high carbohydrate, low protein, low fat diet (55% carbohydrate, 15% protein, 30% fat; AHA) and the Curves moderate carbohydrate restricted, high protein, and low fat diet (30% carbohydrate, 45% protein, 25% fat; CC-I).
Study Type
Interventional
Enrollment (Actual)
86
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 60 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- The participant is an apparently healthy female
- The participant is between the ages of 18 and 60
Exclusion Criteria:
- The participant is pregnant or nursing, or plans to become pregnant during the next 12 months or has been pregnant in the past 12 months
- The participant has uncontrolled metabolic disorder including known electrolyte abnormalities; heart disease, arrhythmias, diabetes, thyroid disease, or hypogonadism; a history of hypertension, hepatorenal, musculoskeletal, autoimmune, or neurological disease
- The participant is currently taking thyroid, hyperlipidemic, hypoglycemic, anti-hypertensive, or androgenic medications
- The participant has taken ergogenic levels of nutritional supplements that may affect muscle mass (e.g., creatine, HMB), anabolic/catabolic hormone levels (androstenedione, DHEA, etc.) or weight loss (e.g., ephedra, thermogenics, etc.) within the past three months
- The participant is willing to participate in a regular moderate exercise program
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: Control
(no diet or exercise intervention)
|
|
Experimental: American Heart Association
(AHA: 55% carbohydrate, 15% protein, 30% fat - diet plus exercise)
|
|
Active Comparator: Curves Complete - I
(CC - I: 30% carbohydrate, 45% protein, 25% fat - diet plus exercise)
|
|
Active Comparator: Curves Complete - II
(CC - II: 20% carbohydrate, 45% protein, 35% fat - diet plus exercise)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Effects of the Curves program on physical activity patterns
Time Frame: 24 weeks
|
24 weeks
|
Effects of the Curves program on body weight
Time Frame: 24 weeks
|
24 weeks
|
Effects of the Curves program on the hip/waist ratio
Time Frame: 24 weeks
|
24 weeks
|
Effects of the Curves program on Resting Energy Expenditure (REE)
Time Frame: 24 weeks
|
24 weeks
|
Effects of the Curves program on Blood Pressure (BP)
Time Frame: 24 weeks
|
24 weeks
|
Effects of the Curves program on Heart Rate (HR)
Time Frame: 24 weeks
|
24 weeks
|
Effects of the Curves program on body composition (DXA)
Time Frame: 24 weeks
|
24 weeks
|
Effects of the Curves program on Bioelectrical Impedance Analysis (BIA)
Time Frame: 24 weeks
|
24 weeks
|
Effects of the Curves program on a chemistry-15 blood panel
Time Frame: 24 weeks
|
24 weeks
|
Effects of the Curves program on a cell blood count (CBC) blood panel
Time Frame: 24 weeks
|
24 weeks
|
Effects of the Curves program on lipid panels
Time Frame: 24 weeks
|
24 weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Effects of the Curves program on maximal cardiopulmonary capacity
Time Frame: 24 weeks
|
24 weeks
|
Effects of the Curves program on muscular strength through a 1 repetition maximum (1 RM) test
Time Frame: 24 weeks
|
24 weeks
|
Effects of the Curves program on muscular endurance through a maximal repetition test
Time Frame: 24 weeks
|
24 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Richard B Kreider, PhD, Texas A&M University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 1, 2013
Primary Completion (Actual)
May 1, 2015
Study Completion (Actual)
May 1, 2015
Study Registration Dates
First Submitted
March 22, 2017
First Submitted That Met QC Criteria
March 22, 2017
First Posted (Actual)
March 28, 2017
Study Record Updates
Last Update Posted (Actual)
March 28, 2017
Last Update Submitted That Met QC Criteria
March 22, 2017
Last Verified
March 1, 2017
More Information
Terms related to this study
Other Study ID Numbers
- IRB2013-0495FX
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diet, Carbohydrate-Restricted
-
University of GlasgowSuspendedDiet, Carbohydrate-restrictedUnited Kingdom
-
Baylor Research InstituteActive, not recruitingHypertension | Risk Reduction Behavior | African Americans | Diet, Carbohydrate-RestrictedUnited States
-
University of DelawareRecruitingDiet, Healthy | Eating Behavior | Nutrition, Healthy | Time Restricted EatingUnited States
-
Horizon Health NetworkRecruitingDiet, Carbohydrate LoadingCanada
-
University of AdelaideAustralian Catholic University; La Trobe UniversityRecruitingDiet Quality | Time-restricted EatingAustralia
-
University of PittsburghCompletedDiet, Sodium-Restricted | Heart Failure C14.280.434United States
-
Barbara Jakše s.p.CompletedBody Weight | Sleep | Cardiovascular Risk Factor | Diet, Healthy | Motivation | Time Restricted FeedingSlovenia
-
University of California, BerkeleyUniversity of British Columbia; University College, London; Wellcome Trust; Salk... and other collaboratorsNot yet recruitingTime Restricted Eating | Diet, MediterraneanUnited States
-
Instituto Mexicano del Seguro SocialCompletedEffect of Sodium Intake on Brain Natriuretic Peptide Levels in Patients With Heart Failure (SODA-HF)Heart Failure, Systolic | Clinical Trial | Natriuretic Peptide, Brain | Diet, Sodium-RestrictedMexico
-
Western University, CanadaUnknowneTRE (Early Time Restricted Eating) | lTRE (Late Time Restricted Eating)Canada
Clinical Trials on Control
-
Claudia M. WittCompleted
-
University of California, San FranciscoWithdrawn
-
The George InstituteChanghai Hospital; University of CalgaryNot yet recruiting
-
Queen's University, BelfastPublic Health Agency, Health and Social Care Research and Development; Tiny...Completed
-
National Taiwan University HospitalEnrolling by invitationCognitive Function | Atrial Fibrillation, PersistentTaiwan
-
Takeshi MorimotoUniversity of the RyukyusActive, not recruitingCoronary Artery Disease | Hypertension | Type 2 Diabetes | DyslipidemiaJapan
-
Johnson & Johnson Vision Care, Inc.TerminatedRefractive Error CorrectionUnited States
-
Universidad Nacional de Educación a DistanciaMinisterio de Economía y Competitividad, SpainUnknownChronic Pain | FibromyalgiaSpain
-
University of California, Los AngelesThe National Council on Aging; City of Los Angeles Department of Aging; Los Angeles...Completed
-
Vanderbilt University Medical CenterCompleted